ResearcherNational Yang Ming Chiao Tung UniversityActive in the last 2 years

Shih‐Ming Hsu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-1846-6381; OpenAlex author ID A5081773915. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 9

Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: 1 paper

Papers 2

Feasibility estimation of injected hydrodissection before definitive radiotherapy of pancreatic adenocarcinoma. Last author DOI 10.1097/jcma.0000000000001084 ↗
Correlation between drug sensitivity profiles of circulating tumour cell-derived organoids and clinical treatment response in patients with pancreatic ductal a… Co-author DOI 10.1016/j.ejca.2022.01.030 ↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Yuan‐Hung Wu · 2 shared papers, 2022–2024 · strength 0.30
- Paper Feasibility estimation of injected hydrodissection before definitive radiotherapy of pancreatic adenocarcinoma. DOI 10.1097/jcma.0000000000001084 ↗
- Paper Correlation between drug sensitivity profiles of circulating tumour cell-derived organoids and clinical treatment respo… DOI 10.1016/j.ejca.2022.01.030 ↗
Chung‐Pin Li · 2 shared papers, 2022–2024 · strength 0.30
- Paper Feasibility estimation of injected hydrodissection before definitive radiotherapy of pancreatic adenocarcinoma. DOI 10.1097/jcma.0000000000001084 ↗
- Paper Correlation between drug sensitivity profiles of circulating tumour cell-derived organoids and clinical treatment respo… DOI 10.1016/j.ejca.2022.01.030 ↗
Keng-Li Lan · 1 shared paper, 2024 · strength 0.19
- Paper Feasibility estimation of injected hydrodissection before definitive radiotherapy of pancreatic adenocarcinoma. DOI 10.1097/jcma.0000000000001084 ↗
Yu‐Wen Hu · 1 shared paper, 2024 · strength 0.19
- Paper Feasibility estimation of injected hydrodissection before definitive radiotherapy of pancreatic adenocarcinoma. DOI 10.1097/jcma.0000000000001084 ↗
Shin‐E Wang · 1 shared paper, 2022 · strength 0.11
- Paper Correlation between drug sensitivity profiles of circulating tumour cell-derived organoids and clinical treatment respo… DOI 10.1016/j.ejca.2022.01.030 ↗
Yi‐Ming Shyr · 1 shared paper, 2022 · strength 0.11
- Paper Correlation between drug sensitivity profiles of circulating tumour cell-derived organoids and clinical treatment respo… DOI 10.1016/j.ejca.2022.01.030 ↗
Long‐Sheng Lu · 1 shared paper, 2022 · strength 0.11
- Paper Correlation between drug sensitivity profiles of circulating tumour cell-derived organoids and clinical treatment respo… DOI 10.1016/j.ejca.2022.01.030 ↗
Jeng-Fong Chiou · 1 shared paper, 2022 · strength 0.11
- Paper Correlation between drug sensitivity profiles of circulating tumour cell-derived organoids and clinical treatment respo… DOI 10.1016/j.ejca.2022.01.030 ↗
Yee Chao · 1 shared paper, 2022 · strength 0.11
- Paper Correlation between drug sensitivity profiles of circulating tumour cell-derived organoids and clinical treatment respo… DOI 10.1016/j.ejca.2022.01.030 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.